The Use of NMDA‐Receptor Antagonists in the Treatment of Chronic Pain

@article{Hewitt2000TheUO,
  title={The Use of NMDA‐Receptor Antagonists in the Treatment of Chronic Pain},
  author={D. Hewitt},
  journal={The Clinical Journal of Pain},
  year={2000},
  volume={16},
  pages={S73–S79}
}
  • D. Hewitt
  • Published 2000
  • Medicine
  • The Clinical Journal of Pain
  • Abstract: Chronic pain can be maintained by a state of sensitization within the central nervous system that is mediated in part by the excitatory amino acids glutamate and aspartate binding to the N‐methyl‐D‐aspartate (NMDA) receptor. A number of antagonists to the NMDA receptor are antinociceptive in animal models but are associated with significant dose‐limiting side effects. Commercially available NMDA‐receptor antagonists include ketamine, dextromethorphan, memantine, and amantadine. The… CONTINUE READING

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    Magnesium exerts analgesic effects in several animal pain models and in patients affected by acute postoperative pain and chronic pain of neuropathic origin. There is no evidence that… Expand
    ConditionsPeripheral Arterial Disease
    InterventionDietary Supplement, Drug
    The Role of N-Methyl-d-Aspartate (NMDA) Receptors in Pain: A Review
    • 543
    • PDF
    NMDA receptors as targets for drug action in neuropathic pain.
    • 208
    Glutamate Receptors and Nociception
    • 167
    Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study.
    • 176
    • PDF
    Polymorphism of human cytochrome P450 enzymes and its clinical impact
    • 568
    Methadone treatment for pain states.
    • 101
    Etiology and Pharmacology of Neuropathic Pain
    • 79
    • PDF